Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway

CONCLUSION: The findings suggest an association between the use of statins and non-selective beta-blockers and reduced pancreatic cancer mortality, and add to the literature supporting the design of randomised clinical trials to evaluate those drugs in the management of pancreatic cancer.PMID:34338111 | DOI:10.1080/0284186X.2021.1953136

Source: Acta Oncologica - August 2, 2021 Category: Cancer & Oncology Authors: Nathalie C St øer Gauthier Bouche Pan Pantziarka Erica K Sloan Bettina K Andreassen Edoardo Botteri Source Type: research